Solstice Advanced Materials, Inc. (SOLS) Market Cap & Valuation Ratios
Solstice Advanced Materials, Inc. (SOLS) has a market cap of $9.4B, a trailing P/E of 45.4 and a price-to-sales ratio of 2.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SOLSSolstice Advanced Materials, Inc.Follow SOLS — free
—
Price chart with a free account
- Market cap
- 9.4B
- P/E TTM
- 45.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
specialty chemicals · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| SOLS | 9.4 | 45.4 | 2.7 | 12.7 | 2.1% | +9% | 16% | 10% |
| DD | 18 | — | 2.8 | 17.1 | 3.8% | +3% | 10% | 3% |
| RPM | 13 | 18.3 | 1.8 | 11.9 | 5.6% | +6% | 13% | 14% |
| ALB | 11 | — | 1.9 | 12.6 | 12.1% | +18% | 4% | 2% |
| WLK | 8.3 | — | 1.0 | — | -3.2% | -4% | -11% | -10% |
| ESI | 8.1 | 39.1 | 2.8 | 17.1 | 2.3% | +40% | 12% | 6% |
| NEU | 8.0 | 18.7 | 3.2 | 13.0 | 5.9% | -1% | 20% | 17% |
| EMN | 7.4 | 16.9 | 1.3 | 9.4 | 7.3% | -5% | 8% | 6% |
| AXTA | 7.3 | 21.1 | 1.9 | 9.9 | 6.8% | -0.9% | 13% | 9% |
| SXT | 5.6 | 35.8 | 3.7 | 21.2 | 0.1% | +8% | 14% | 9% |
| BCPC | 5.6 | 33.3 | 5.1 | 20.5 | 3.2% | +9% | 21% | 13% |
| Median of these 10 | 21.1 | 2.4 | 13.0 | 4.7% | +5% | 12% | 8% |
P/E 45.4 vs. a peer median of 21.1; EV/Sales 2.7 vs. 2.4.
Growth vs. price
each dot a company · hover or tap for valuesDD and ALB and WLK have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Solstice Advanced Materials, Inc. — questions
- What is Solstice Advanced Materials, Inc.'s market cap?
- $9.4B.
- What is Solstice Advanced Materials, Inc.'s P/E ratio?
- 45.4 on trailing twelve-month earnings to 2026-06-30.
- What is Solstice Advanced Materials, Inc.'s price-to-sales ratio?
- 2.3.
Every figure on this page comes from Solstice Advanced Materials, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.